학술논문
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: The phase IV MITO-16A/MaNGO-OV2A study
Document Type
Article
Author
Daniele, G.; Piccirillo, M.C.; Arenare, L.; Perrone, F.; Raspagliesi, F.; Lorusso, D.; Bogani, G.; Scambia, G.; Salutari, V.; Distefano, M.; Pisano, C.; Cecere, S.C.; Pignata, S.; Colombo, N.; Zaccarelli, E.; Frezzini, S.; Tognon, G.; Artioli, G.; Gadducci, A.; Lauria, R.; Ferrero, A.; Cinieri, S.; De Censi, A.; Breda, E.; Scollo, P.; De Giorgi, U.; Lissoni, A.A.; Katsaros, D.; Nardin, M.; Greggi, S.; Fossati, R.; Giannone, G.; Gallo, C.
Source
In: International Journal of Gynecological Cancer . (International Journal of Gynecological Cancer, 1 June 2021, 31(6):875-882)
Subject
Language
English
ISSN
15251438
1048891X
1048891X